These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8225635)

  • 41. [Application of transumbilical antibacterial therapy in patients with acute purulent cholangitis].
    Shkurupiĭ OA
    Klin Khir; 2011 Mar; (3):22-4. PubMed ID: 21695967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of serious infections with intravenous ciprofloxacin. French Multicenter Study Group.
    Modai J
    Am J Med; 1989 Nov; 87(5A):243S-247S. PubMed ID: 2686426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intravenous/oral ciprofloxacin therapy of infections caused by multiresistant bacteria.
    Neu HC; Davidson S; Briones F
    Am J Med; 1989 Nov; 87(5A):209S-212S. PubMed ID: 2511758
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections.
    Khan FA; Basir R
    Chest; 1989 Sep; 96(3):528-37. PubMed ID: 2670465
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sequential intravenous and oral ciprofloxacin versus intravenous ceftazidime in the treatment of complicated urinary tract infections.
    Cox CE
    Am J Med; 1989 Nov; 87(5A):157S-159S. PubMed ID: 2686415
    [No Abstract]   [Full Text] [Related]  

  • 46. Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group.
    Solomkin JS; Reinhart HH; Dellinger EP; Bohnen JM; Rotstein OD; Vogel SB; Simms HH; Hill CS; Bjornson HS; Haverstock DC; Coulter HO; Echols RM
    Ann Surg; 1996 Mar; 223(3):303-15. PubMed ID: 8604912
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Ciprofloxacin by the intravenous route in the treatment of respiratory infections].
    Mangiarotti P; Manara G; Bianchi L; Piccioni PD; Grassi C
    G Ital Chemioter; 1989; 36(1-3):89-94. PubMed ID: 2488917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antibiotics in the treatment of biliary tract infections].
    Perkowski H
    Wiad Lek; 1989 Jan; 42(2):101-5. PubMed ID: 2683383
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.
    Pérez-Ruvalcaba JA; Quintero-Pérez NP; Morales-Reyes JJ; Huitrón-Ramírez JA; Rodríguez-Chagollán JJ; Rodríguez-Noriega E
    Am J Med; 1987 Apr; 82(4A):242-6. PubMed ID: 3555042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenous ciprofloxacin or ceftazidime in selected infections. A prospective, randomized, controlled study.
    Villavicencio J; Asensio de Fernandez ME; Ramirez CA
    Am J Med; 1989 Nov; 87(5A):191S-194S. PubMed ID: 2686422
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibiotics in infections of the biliary tract.
    Muller EL; Pitt HA; Thompson JE; Doty JE; Mann LL; Manchester B
    Surg Gynecol Obstet; 1987 Oct; 165(4):285-92. PubMed ID: 3310282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cefazolin in the treatment of biliary tract infections.
    Paulet P
    Acta Gastroenterol Belg; 1976; 39(7-8):293-7. PubMed ID: 1015201
    [No Abstract]   [Full Text] [Related]  

  • 53. Acute reversible renal failure in patients with acute cholecystitis and cholangitis.
    Burden RP; Ash DV; Boyd WN; Gray JG; ABER GM
    Q J Med; 1975 Jan; 44(173):65-77. PubMed ID: 1098091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Randomized, double-blind comparative study of intravenous ciprofloxacin versus ceftazidime in the treatment of serious infections.
    Levine DP; McNeil P; Lerner SA
    Am J Med; 1989 Nov; 87(5A):160S-163S. PubMed ID: 2686416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of intravenous ciprofloxacin in the treatment of serious infections. A comparison with ceftazidime.
    Quintero-Perez NP; Andrade-Villaneuva JF; Leon-Garnica G; Bertin-Montano M; Rodriguez-Chagollan JJ; Rodriguez-Noriega E
    Am J Med; 1989 Nov; 87(5A):198S-201S. PubMed ID: 2686424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acalculous nontyphoidal salmonellal cholecystitis requiring surgical intervention despite ciprofloxacin therapy: report of three cases.
    McCarron B; Love WC
    Clin Infect Dis; 1997 Apr; 24(4):707-9. PubMed ID: 9145746
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Induced antibiotic-resistant bacteria in cholangitis with biliary stasis.
    Demediuk B; Speer AG; Hellyar A
    Aust N Z J Surg; 1996 Nov; 66(11):778-80. PubMed ID: 8918392
    [No Abstract]   [Full Text] [Related]  

  • 58. Microbiology of bile in patients with cholangitis or cholestasis with and without plastic biliary endoprosthesis.
    Rerknimitr R; Fogel EL; Kalayci C; Esber E; Lehman GA; Sherman S
    Gastrointest Endosc; 2002 Dec; 56(6):885-9. PubMed ID: 12447303
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Morpho-functional study of the liver after treatment with gentamicin in cases of biliary tract infections].
    Gasbarrini G; Miglio F; Bernardi M; Bonvicini F; Corazza G
    Minerva Gastroenterol; 1974; 20(3):83-9. PubMed ID: 4467043
    [No Abstract]   [Full Text] [Related]  

  • 60. Intravenous ciprofloxacin for infections in cancer patients.
    Rolston KV; Haron E; Cunningham C; Bodey GP
    Am J Med; 1989 Nov; 87(5A):261S-265S. PubMed ID: 2589375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.